Abstract
High body weight is associated with increased production of oestrogens which may influence the clinical behaviour of breast cancer. We have examined the influence of body weight on the response to endocrine therapy, steroid hormone receptor content and survival in 227 women who either presented with or developed advanced cancer of the breast. One hundred and thirty-three (59%) patients presented with operable disease and 94 (41%) with locally advanced tumours. Two hundred (88%) were treated by tamoxifen and 27 (12%) by ovarian ablation. High body weight was correlated with advanced tumour stage (P = 0.002) and progesterone receptor (PR) positivity (P = 0.01), but not with the presence of oestrogen receptor (ER P = 0.21). The association between high body weight and PR positivity was particularly noticeable among ER positive tumours. There was no significant relationship between the nature of the response to therapy and weight (P = 0.57). There was no significant difference in survival from the start of endocrine therapy (P = 0.95), nor the time to progression of disease (P = 0.29) between patients above and below the median weight of 64 kg. Among the patients with operable disease, there was no difference in overall survival (P = 0.42), relapse free survival (P = 0.69), and survival from the start of endocrine therapy (P = 0.85) according to body weight.
Full text
PDFSelected References
These references are in PubMed. This may not be the complete list of references from this article.
- Abe R., Kumagai N., Kimura M., Hirosaki A., Nakamura T. Biological characteristics of breast cancer in obesity. Tohoku J Exp Med. 1976 Dec;120(4):351–359. doi: 10.1620/tjem.120.351. [DOI] [PubMed] [Google Scholar]
- Adami H. O., Killander D. Prediction of survival in breast cancer. Principles and current status of hormone receptors and DNA content as prognostic factors. Acta Chir Scand Suppl. 1984;519:25–34. [PubMed] [Google Scholar]
- Boyd N. F., Campbell J. E., Germanson T., Thomson D. B., Sutherland D. J., Meakin J. W. Body weight and prognosis in breast cancer. J Natl Cancer Inst. 1981 Oct;67(4):785–789. [PubMed] [Google Scholar]
- De Waard F., Cornelis J. P., Aoki K., Yoshida M. Breast cancer incidence according to weight and height in two cities of the Netherlands and in Aichi prefecture, Japan. Cancer. 1977 Sep;40(3):1269–1275. doi: 10.1002/1097-0142(197709)40:3<1269::aid-cncr2820400341>3.0.co;2-s. [DOI] [PubMed] [Google Scholar]
- Donegan W. L., Hartz A. J., Rimm A. A. The association of body weight with recurrent cancer of the breast. Cancer. 1978 Apr;41(4):1590–1594. doi: 10.1002/1097-0142(197804)41:4<1590::aid-cncr2820410449>3.0.co;2-n. [DOI] [PubMed] [Google Scholar]
- Eberlein T., Simon R., Fisher S., Lippman M. E. Height, weight, and risk of breast cancer relapse. Breast Cancer Res Treat. 1985;5(1):81–86. doi: 10.1007/BF01807654. [DOI] [PubMed] [Google Scholar]
- Greenberg E. R., Vessey M. P., McPherson K., Doll R., Yeates D. Body size and survival in premenopausal breast cancer. Br J Cancer. 1985 May;51(5):691–697. doi: 10.1038/bjc.1985.104. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Harland R. N., Hayward E., Barnes D. M. Progesterone receptor measurement by isoelectric focusing: a potential microassay. Clin Chim Acta. 1983 Sep 30;133(2):159–168. doi: 10.1016/0009-8981(83)90401-1. [DOI] [PubMed] [Google Scholar]
- Longcope C. Metabolic clearance and blood production rates of estrogens in postmenopausal women. Am J Obstet Gynecol. 1971 Nov;111(6):778–781. doi: 10.1016/0002-9378(71)90488-1. [DOI] [PubMed] [Google Scholar]
- MacDonald P. C., Edman C. D., Hemsell D. L., Porter J. C., Siiteri P. K. Effect of obesity on conversion of plasma androstenedione to estrone in postmenopausal women with and without endometrial cancer. Am J Obstet Gynecol. 1978 Feb 15;130(4):448–455. doi: 10.1016/0002-9378(78)90287-9. [DOI] [PubMed] [Google Scholar]
- Newman S. C., Miller A. B., Howe G. R. A study of the effect of weight and dietary fat on breast cancer survival time. Am J Epidemiol. 1986 May;123(5):767–774. doi: 10.1093/oxfordjournals.aje.a114305. [DOI] [PubMed] [Google Scholar]
- Papatestas A. E., Miller S. R., Pertsemlidis D., Fagerstrom R., Lesnick G., Aufses A. H. Association between prognosis and hormone receptors in women with breast cancer. Cancer Detect Prev. 1986;9(3-4):303–310. [PubMed] [Google Scholar]
- Rizkallah T. H., Tovell H. M., Kelly W. G. Production of estrone and fractional conversion of circulating androstenedione to estrone in women with endometrial carcinoma. J Clin Endocrinol Metab. 1975 Jun;40(6):1045–1056. doi: 10.1210/jcem-40-6-1045. [DOI] [PubMed] [Google Scholar]
- Sohrabi A., Sandoz J., Spratt J. S., Polk H. C., Jr Recurrence of breast cancer. Obesity, tumor size, and axillary lymph node metastases. JAMA. 1980 Jul 18;244(3):264–265. doi: 10.1001/jama.244.3.264. [DOI] [PubMed] [Google Scholar]
- Tartter P. I., Papatestas A. E., Ioannovich J., Mulvihill M. N., Lesnick G., Aufses A. H., Jr Cholesterol and obesity as prognostic factors in breast cancer. Cancer. 1981 May 1;47(9):2222–2227. doi: 10.1002/1097-0142(19810501)47:9<2222::aid-cncr2820470919>3.0.co;2-5. [DOI] [PubMed] [Google Scholar]
- Waxler S. H., Brecher G., Beal S. L. The effect of fat-enriched diet on the incidence of spontaneous mammary tumors in obese mice. Proc Soc Exp Biol Med. 1979 Nov;162(2):365–368. doi: 10.3181/00379727-162-40683. [DOI] [PubMed] [Google Scholar]
- de Waard F. Nutritional etiology of breast cancer: where are we now, and where are we going? Nutr Cancer. 1982;4(2):85–89. doi: 10.1080/01635588209513743. [DOI] [PubMed] [Google Scholar]
- de Waard F., Poortman J., Collette B. J. Relationship of weight to the promotion of breast cancer after menopause. Nutr Cancer. 1981;2(4):237–240. doi: 10.1080/01635588109513689. [DOI] [PubMed] [Google Scholar]